BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹3,111 Cr | ₹1,952 Cr | ₹-180 Cr | ₹3,823 Cr | ₹4,554 Cr |
What is the latest Net Current Assets ratio of BIOCON ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹3,111 Cr |
| Mar2025 | ₹1,952 Cr |
| Mar2024 | ₹-180 Cr |
| Mar2023 | ₹3,823 Cr |
| Mar2022 | ₹4,554 Cr |
How is Net Current Assets of BIOCON Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,111 Cr | 59.32 | |
| Mar2025 | ₹1,952 Cr | Positive | |
| Mar2024 | ₹-180 Cr | Negative | |
| Mar2023 | ₹3,823 Cr | -16.05 | |
| Mar2022 | ₹4,554 Cr | - | |
Compare Net Current Assets of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹67,518.5 Cr | -2.5% | -4.2% | 20.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -2.5% |
-4.2% |
20.5% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses